172 related articles for article (PubMed ID: 32407811)
1. An exploratory analysis on the influence of genetic variants on weight gain among etonogestrel contraceptive implant users.
Lazorwitz A; Dindinger E; Harrison M; Aquilante CL; Sheeder J; Teal S
Contraception; 2020 Sep; 102(3):180-185. PubMed ID: 32407811
[TBL] [Abstract][Full Text] [Related]
2. Influence of Genetic Variants on Steady-State Etonogestrel Concentrations Among Contraceptive Implant Users.
Lazorwitz A; Aquilante CL; Oreschak K; Sheeder J; Guiahi M; Teal S
Obstet Gynecol; 2019 Apr; 133(4):783-794. PubMed ID: 30870275
[TBL] [Abstract][Full Text] [Related]
3. Assessing Weight Status in Adolescent and Young Adult Users of the Etonogestrel Contraceptive Implant.
Romano ME; Braun-Courville DK
J Pediatr Adolesc Gynecol; 2019 Aug; 32(4):409-414. PubMed ID: 30928532
[TBL] [Abstract][Full Text] [Related]
4. Applicability of ancestral genotyping in pharmacogenomic research with hormonal contraception.
Lazorwitz A; Aquilante CL; Shortt JA; Sheeder J; Teal S; Gignoux CR
Clin Transl Sci; 2021 Sep; 14(5):1713-1718. PubMed ID: 33650294
[TBL] [Abstract][Full Text] [Related]
5. The effect of immediate postpartum compared to delayed postpartum and interval etonogestrel contraceptive implant insertion on removal rates for bleeding.
Ireland LD; Goyal V; Raker CA; Murray A; Allen RH
Contraception; 2014 Sep; 90(3):253-8. PubMed ID: 24973904
[TBL] [Abstract][Full Text] [Related]
6. Relationship between patient characteristics and serum etonogestrel concentrations in contraceptive implant users.
Lazorwitz A; Aquilante CL; Sheeder J; Guiahi M; Teal S
Contraception; 2019 Jul; 100(1):37-41. PubMed ID: 30980827
[TBL] [Abstract][Full Text] [Related]
7. An exploratory study on the association of lifestyle factors with serum etonogestrel concentrations among contraceptive implant users.
Lazorwitz A; Sheeder J; Teal S
Eur J Contracept Reprod Health Care; 2021 Aug; 26(4):323-325. PubMed ID: 33596152
[TBL] [Abstract][Full Text] [Related]
8. Immediate versus delayed insertion of an etonogestrel releasing implant at medical abortion-a randomized controlled equivalence trial.
Hognert H; Kopp Kallner H; Cameron S; Nyrelli C; Jawad I; Heller R; Aronsson A; Lindh I; Benson L; Gemzell-Danielsson K
Hum Reprod; 2016 Nov; 31(11):2484-2490. PubMed ID: 27664217
[TBL] [Abstract][Full Text] [Related]
9. Relationship Between Etonogestrel Concentrations and Bleeding Patterns in Contraceptive Implant Users.
Lazorwitz A; Aquilante CL; Dindinger E; Harrison M; Sheeder J; Teal S
Obstet Gynecol; 2019 Oct; 134(4):807-813. PubMed ID: 31503152
[TBL] [Abstract][Full Text] [Related]
10. Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food and Drug Administration-approved duration.
McNicholas C; Swor E; Wan L; Peipert JF
Am J Obstet Gynecol; 2017 Jun; 216(6):586.e1-586.e6. PubMed ID: 28147241
[TBL] [Abstract][Full Text] [Related]
11. An exploratory study on the possible association of serum etonogestrel concentrations with mood concerns and symptoms among contraceptive implant users.
Diamond B; Sheeder J; Lazorwitz A
Contraception; 2024 Jan; 129():110298. PubMed ID: 37802462
[TBL] [Abstract][Full Text] [Related]
12. Comparison of weight gain between levonorgestrel and etonogestrel implants after 12 months of insertion.
Okunola TO; Bola-Oyebamiji SB; Sowemimo O
Int J Gynaecol Obstet; 2019 Oct; 147(1):54-58. PubMed ID: 31265128
[TBL] [Abstract][Full Text] [Related]
13. Etonogestrel contraceptive implant uptake and safety among solid organ transplant recipients.
Lew J; Sheeder J; Lazorwitz A
Contraception; 2021 Nov; 104(5):556-560. PubMed ID: 34147509
[TBL] [Abstract][Full Text] [Related]
14. Combined oral contraceptive treatment for bleeding complaints with the etonogestrel contraceptive implant: a randomised controlled trial.
Hou MY; McNicholas C; Creinin MD
Eur J Contracept Reprod Health Care; 2016 Oct; 21(5):361-6. PubMed ID: 27419258
[TBL] [Abstract][Full Text] [Related]
15. Amenorrhea in adolescents using the etonogestrel contraceptive implant.
Tsevat D; Mercier R; Bernheimer C; Lin S; Schwartz B
Contraception; 2024 May; 133():110413. PubMed ID: 38401772
[TBL] [Abstract][Full Text] [Related]
16. Influence of age on tolerability, safety and effectiveness of subdermal contraceptive implants.
López Del Cerro E; Serrano Diana C; Castillo Cañadas AM; González Mirasol E; García Santos F; Gómez García MT; González de Merlo G
J Obstet Gynaecol; 2018 Oct; 38(7):979-984. PubMed ID: 29553853
[TBL] [Abstract][Full Text] [Related]
17. Etonogestrel implant use in women primarily choosing a combined oral contraceptive pill: A proof-of-concept trial.
Chen MJ; Hsia JK; Creinin MD
Contraception; 2018 Jun; 97(6):533-537. PubMed ID: 29496473
[TBL] [Abstract][Full Text] [Related]
18. The effect of carbamazepine on etonogestrel concentrations in contraceptive implant users.
Lazorwitz A; Davis A; Swartz M; Guiahi M
Contraception; 2017 Jun; 95(6):571-577. PubMed ID: 28288788
[TBL] [Abstract][Full Text] [Related]
19. A pilot study on the effect of isotretinoin on serum etonogestrel concentrations in contraceptive implant users.
Lazorwitz A; Seale R; Davis A; Guiahi M
Contraception; 2020 Jul; 102(1):58-60. PubMed ID: 32325076
[TBL] [Abstract][Full Text] [Related]
20. Early removal of etonogestrel subcutaneous contraceptive implant at a community health centre in Pretoria.
Moeti DMP; Govender I; Bongongo T
S Afr Fam Pract (2004); 2022 Jul; 64(1):e1-e6. PubMed ID: 35924618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
